Area under the curve or 'AUC' obtained by adding 0 for no response and 1 for an ACR 20 response for visits on Day 112, 140, and 168 time points 112, 140 and 168 of the 6-month trial [clinicaltrials_resource:bf0a5593d34f9393d734319d3e868b72]
Subjects randomized to arm A received 25mg/day po of placebo
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Area under the curve or 'AUC' obtained by adding 0 for no response and 1 for an ACR 20 response for visits on Day 112, 140, and 168 time points 112, 140 and 168 of the 6-month trial [clinicaltrials_resource:bf0a5593d34f9393d734319d3e868b72]
Subjects randomized to arm A received 25mg/day po of placebo
Bio2RDF identifier
bf0a5593d34f9393d734319d3e868b72
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:bf0a5593d34f9393d734319d3e868b72
measure [clinicaltrials_vocabulary:measure]
Area under the curve or 'AUC' ...... isits on Day 112, 140, and 168
time frame [clinicaltrials_vocabulary:time-frame]
time points 112, 140 and 168 of the 6-month trial
description
Subjects randomized to arm A received 25mg/day po of placebo
identifier
clinicaltrials_resource:bf0a5593d34f9393d734319d3e868b72
title
Area under the curve or 'AUC' ...... 0 and 168 of the 6-month trial
@en
type
label
Area under the curve or 'AUC' ...... a5593d34f9393d734319d3e868b72]
@en